LEVOTHYROXINE SODIUM | A207588 | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.0999
per ea
Lowest NADAC/Unit
$0.0357
per ea
Brand NDCs
0
Generic NDCs
20
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00480872598LEVOTHYROXINE 300 MCG TABLET | $0.0999 | EA | Generic | — | 2026-08-19 |
| 00480872510LEVOTHYROXINE 300 MCG TABLET | $0.0999 | EA | Generic | — | 2026-08-19 |
| 00480872298LEVOTHYROXINE 200 MCG TABLET | $0.0802 | EA | Generic | — | 2026-08-19 |
| 00480872210LEVOTHYROXINE 200 MCG TABLET | $0.0802 | EA | Generic | — | 2026-08-19 |
| 00480871810LEVOTHYROXINE 175 MCG TABLET | $0.0765 | EA | Generic | — | 2026-08-19 |
| 00480871898LEVOTHYROXINE 175 MCG TABLET | $0.0765 | EA | Generic | — | 2026-08-19 |
Showing 6 of 20 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.